TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.290
-0.010 (-0.77%)
At close: Feb 11, 2026, 4:00 PM EST
1.330
+0.040 (3.10%)
After-hours: Feb 11, 2026, 7:02 PM EST
TuHURA Biosciences Employees
TuHURA Biosciences had 19 employees as of December 31, 2024. The number of employees increased by 18 or 1,800.00% compared to the previous year.
Employees
19
Change (1Y)
18
Growth (1Y)
1,800.00%
Revenue / Employee
n/a
Profits / Employee
-$1,541,833
Market Cap
78.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 70 |
| Kezar Life Sciences | 55 |
| LeonaBio | 26 |
| Lisata Therapeutics | 26 |
| Plus Therapeutics | 21 |
| NeurAxis | 21 |
| ABVC BioPharma | 19 |
| Atossa Therapeutics | 15 |
HURA News
- 9 days ago - TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - PRNewsWire
- 2 months ago - TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - PRNewsWire
- 2 months ago - TuHURA Biosciences Provides Corporate Update Following Recent Financing - PRNewsWire
- 2 months ago - TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering - PRNewsWire
- 2 months ago - TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition - PRNewsWire
- 3 months ago - TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - PRNewsWire
- 3 months ago - TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition - PRNewsWire
- 6 months ago - TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference - PRNewsWire